Atorvastatin Calcium
Product Images NDC 54868-6322

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 54868-6322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Bottle Label (6319)

Atorvastatin Calcium 10 mg tablets packaging label by Physicians Total Care, Inc. The label indicates 30 tablets per container and includes dosage strength and caution about federal dispensing restrictions. Batch, expiration date, and barcode are also visible.*

FDA Label Image

20mg Bottle Label (6320)

Atorvastatin Calcium 20 MG tablets packaging label by Physicians Total Care, Inc. The label indicates a quantity of 30 tablets per container with a caution about federal law requiring a prescription for dispensing. It includes dosage information and storage instructions, plus a barcode and lot, expiration details.*

FDA Label Image

40mg Bottle Label (6321)

Atorvastatin Calcium 40 MG tablets packaging label from Physicians Total Care, Inc. The label states the quantity as 30 tablets, includes a caution that federal law prohibits dispensing without a prescription, and provides various storage and handling instructions. The label also displays lot and expiration information, a barcode, and the labeler's name and address.*

FDA Label Image

80mg Bottle Label (6322)

Atorvastatin Calcium 80 MG tablets label from Physicians Total Care, Inc. The label indicates a package count of 30 tablets. It includes dosage information, caution against dispensing without prescription, storage instructions, and manufacturer details. The label also shows the National Drug Code (NDC) and lot number information.*

FDA Label Image

Figure1 (Figatorva1)

A line graph comparing cumulative incidence (%) over a period of 3.5 years for Atorvastatin versus Placebo. The graph shows lower cumulative incidence for Atorvastatin than Placebo, with a hazard ratio (HR) and p-value indicated in the lower right corner.*

FDA Label Image

Figure2 (Figatorva2)

A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin groups, showing time to first primary endpoint through four years of follow-up. The graph includes hazard ratio and p-value statistics, illustrating lower cumulative hazard in the atorvastatin group compared to placebo.*

FDA Label Image

Figure3 (Figatorva3)

A Kaplan-Meier survival curve chart showing the percentage of subjects experiencing a major cardiovascular endpoint over five years for Atorvastatin 10 mg and 80 mg dosages. The graph compares the event rates over time with hazard ratio and p-value noted.*

FDA Label Image

Structure (Structureatorva)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, fluorine atom, and calcium ion complex.*

FDA Label Image

Table 3 (Table3rev)

A data table titled 'Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin' showing various co-administered drugs with dosing regimens, atorvastatin doses, and changes in pharmacokinetic parameters AUC and Cmax expressed as fold changes or percentages. The table includes drugs such as Cyclosporine, Tipranavir, Telaprevir, and others, with notes on data interpretation and clinical significance provided below the table.*

FDA Label Image

Table 4 (Table4)

A data table titled 'Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs' showing various dosing regimens of Atorvastatin and their effects on co-administered drugs, including changes in AUC and Cmax percentages for drugs like Antipyrine, Digoxin, oral contraceptives, Tipranavir/ritonavir, and Fosamprenavir. Footnote refers to clinical significance information in Section 7.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.